PURE Bioscience Appoints Dave Pfanzelter to Board of Directors

Published: Feb 13, 2013

PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that food industry leader Dave Pfanzelter has been appointed to the Board of Directors. Mr. Pfanzelter has been a member of PURE Bioscience’s Advisory Panel since July 2012. His appointment increases the number of PURE directors to six, four of whom are considered independent, including Mr. Pfanzelter.

Back to news